{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:13:44Z","timestamp":1773004424409,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,8]]},"DOI":"10.7759\/cureus.104860","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T18:36:51Z","timestamp":1772995011000},"source":"Crossref","is-referenced-by-count":0,"title":["Reliability of the E-test and VITEK 2 Compact for Tigecycline Susceptibility Testing in Clinical Acinetobacter baumannii Isolates Compared With Broth Microdilution"],"prefix":"10.7759","author":[{"given":"Amresh","family":"Pati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal Ahmad","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashoka","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics15010002","article-title":"Multidrug-resistant Acinetobacter baumannii: resistance mechanisms, emerging therapies, and prevention\u2014a narrative review","volume":"15","author":"Stoian IA","year":"2025","unstructured":"Stoian IA, Balas Maftei B, Florea CE, et al.. Multidrug-resistant Acinetobacter baumannii: resistance mechanisms, emerging therapies, and prevention\u2014a narrative review. Antibiotics (Basel). 2025, 15:10.3390\/antibiotics15010002","journal-title":"Antibiotics (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010085","article-title":"The evolution of antimicrobial resistance in Acinetobacter baumannii and new strategies to fight it","volume":"14","author":"Scoffone VC","year":"2025","unstructured":"Scoffone VC, Trespidi G, Barbieri G, Arshad A, Israyilova A, Buroni S. The evolution of antimicrobial resistance in Acinetobacter baumannii and new strategies to fight it. Antibiotics (Basel). 2025, 14:10.3390\/antibiotics14010085","journal-title":"Antibiotics (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"Pogue JM","year":"2011","unstructured":"Pogue JM, Lee J, Marchaim D, et al.. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 2011, 53:879-84. 10.1093\/cid\/cir611","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.12.004","article-title":"Tigecycline: an update","volume":"75","author":"Stein GE","year":"2013","unstructured":"Stein GE, Babinchak T. Tigecycline: an update. Diagn Microbiol Infect Dis. 2013, 75:331-6. 10.1016\/j.diagmicrobio.2012.12.004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki248","article-title":"Tigecycline","volume":"56","author":"Pankey GA","year":"2005","unstructured":"Pankey GA. Tigecycline. J Antimicrob Chemother. 2005, 56:470-80. 10.1093\/jac\/dki248","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ijmm.IJMM_19_207","article-title":"Bad bug, no test: tigecycline susceptibility testing challenges and way forward","volume":"37","author":"Shankar C","year":"2019","unstructured":"Shankar C, Pragasam AK, Veeraraghavan B, Amladi A. Bad bug, no test: tigecycline susceptibility testing challenges and way forward. Indian J Med Microbiol. 2019, 37:91-4. 10.4103\/ijmm.IJMM_19_207","journal-title":"Indian J Med Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2018.03.011","article-title":"Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii","volume":"91","author":"Idelevich EA","year":"2018","unstructured":"Idelevich EA, Freeborn DA, Seifert H, Becker K. Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2018, 91:360-2. 10.1016\/j.diagmicrobio.2018.03.011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.201601","article-title":"Trends in drug resistance of Acinetobacter baumannii over a 10-year period: nationwide data from the China surveillance of antimicrobial resistance program","volume":"130","author":"Gao L","year":"2017","unstructured":"Gao L, Lyu Y, Li Y. Trends in drug resistance of Acinetobacter baumannii over a 10-year period: nationwide data from the China surveillance of antimicrobial resistance program. Chin Med J (Engl). 2017, 130:659-64. 10.4103\/0366-6999.201601","journal-title":"Chin Med J (Engl)"},{"key":"ref9","article-title":"Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 10.0, 2020","author":"EUCAST","year":"2020","unstructured":"EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 10.0, 2020. European Committee on Antimicrobial Susceptibility Testing (EUCAST), V\u00e4xj\u00f6, Sweden; 2020."},{"key":"ref10","article-title":"Performance Standards for Antimicrobial Susceptibility Testing. 30th ed","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2020","unstructured":"Clinical and Laboratory Standards Institute (CLSI).  Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA; 2020."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries RM","year":"2018","unstructured":"Humphries RM, Ambler J, Mitchell SL, et al.. CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests. J Clin Microbiol. 2018, 56:10.1128\/JCM.01934-17","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2017.0251","article-title":"Comparative evaluation of broth microdilution with polystyrene and glass-coated plates, agar dilution, E-test, Vitek, and disk diffusion for susceptibility testing of colistin and polymyxin B on carbapenem-resistant clinical isolates of Acinetobacter baumannii","volume":"24","author":"Singhal L","year":"2018","unstructured":"Singhal L, Sharma M, Verma S, et al.. Comparative evaluation of broth microdilution with polystyrene and glass-coated plates, agar dilution, E-test, Vitek, and disk diffusion for susceptibility testing of colistin and polymyxin B on carbapenem-resistant clinical isolates of Acinetobacter baumannii. Microb Drug Resist. 2018, 24:1082-8. 10.1089\/mdr.2017.0251","journal-title":"Microb Drug Resist"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.11.020","article-title":"Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp","volume":"24","author":"Matuschek E","year":"2018","unstructured":"Matuschek E, \u00c5hman J, Webster C, Kahlmeter G. Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clin Microbiol Infect. 2018, 24:865-70. 10.1016\/j.cmi.2017.11.020","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S260643","article-title":"Acinetobacter baumannii sequence types harboring genes encoding aminoglycoside modifying enzymes and 16SrRNA methylase; a multicenter study from Pakistan","volume":"13","author":"Khurshid M","year":"2020","unstructured":"Khurshid M, Rasool MH, Ashfaq UA, et al.. Acinetobacter baumannii sequence types harboring genes encoding aminoglycoside modifying enzymes and 16SrRNA methylase; a multicenter study from Pakistan. Infect Drug Resist. 2020, 13:2855-62. 10.2147\/IDR.S260643","journal-title":"Infect Drug Resist"},{"key":"ref15","unstructured":"Tygacil\u00ae. (2005). Accessed. January 22, 2026: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2005\/021821lbl.pdf."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky276","article-title":"Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study","volume":"73","author":"Haldorsen B","year":"2018","unstructured":"Haldorsen B, Giske CG, Hansen DS, et al.. Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study. J Antimicrob Chemother. 2018, 73:2738-47. 10.1093\/jac\/dky276","journal-title":"J Antimicrob Chemother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.12.024","article-title":"Inter-technique variability between antimicrobial susceptibility testing methods affects clinical classification of cefuroxime in strains close to breakpoint","volume":"26","author":"Ballestero-T\u00e9llez M","year":"2020","unstructured":"Ballestero-T\u00e9llez M, Jim\u00e9nez-Morgades E, Arjona-Camacho P, Blanco-Su\u00e1rez A, Padilla-Esteba E, P\u00e9rez-Jov\u00e9 J. Inter-technique variability between antimicrobial susceptibility testing methods affects clinical classification of cefuroxime in strains close to breakpoint. Clin Microbiol Infect. 2020, 26:648.e1-3. 10.1016\/j.cmi.2019.12.024","journal-title":"Clin Microbiol Infect"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03703.x","article-title":"EUCAST expert rules in antimicrobial susceptibility testing","volume":"19","author":"Leclercq R","year":"2013","unstructured":"Leclercq R, Cant\u00f3n R, Brown DF, et al.. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2013, 19:141-60. 10.1111\/j.1469-0691.2011.03703.x","journal-title":"Clin Microbiol Infect"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-04123-z","article-title":"Performance of VITEK 2, E-test, Kirby-Bauer disk diffusion, and modified Kirby-Bauer disk diffusion compared to reference broth microdilution for testing tigecycline susceptibility of carbapenem-resistant K. pneumoniae and A. baumannii in a multicenter study in China","volume":"40","author":"Yin D","year":"2021","unstructured":"Yin D, Guo Y, Li M, et al.. Performance of VITEK 2, E-test, Kirby-Bauer disk diffusion, and modified Kirby-Bauer disk diffusion compared to reference broth microdilution for testing tigecycline susceptibility of carbapenem-resistant K. pneumoniae and A. baumannii in a multicenter study in China. Eur J Clin Microbiol Infect Dis. 2021, 40:1149-54. 10.1007\/s10096-020-04123-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/JLP.JLP_72_18","article-title":"A 5-year surveillance on antimicrobial resistance of Acinetobacter isolates at a level-I trauma centre of India","volume":"11","author":"Kumari M","year":"2019","unstructured":"Kumari M, Batra P, Malhotra R, Mathur P. A 5-year surveillance on antimicrobial resistance of Acinetobacter isolates at a level-I trauma centre of India. J Lab Physicians. 2019, 11:34-8. 10.4103\/JLP.JLP_72_18","journal-title":"J Lab Physicians"},{"key":"ref21","article-title":"Tigecycline susceptibility report from an Indian tertiary care hospital","volume":"129(4)","author":"Behera B","year":"2009","unstructured":"Behera B, Das A, Mathur P, Kapil A, Gadepalli R, Dhawan B. Tigecycline susceptibility report from an Indian tertiary care hospital. Indian J Med Res. 2009, 129(4):446-50.","journal-title":"Indian J Med Res"},{"key":"ref22","article-title":"Evaluation of in vitro tigecycline activity against multidrug-resistant Acinetobacter baumannii clinical isolates from Poland","volume":"74(3)","author":"Paluchowska P","year":"2017","unstructured":"Paluchowska P, Nowak P, Skalkowska M, Bjdak A. Evaluation of in vitro tigecycline activity against multidrug-resistant Acinetobacter baumannii clinical isolates from Poland. Acta Pol Pharm. 2017, 74(3):793-800.","journal-title":"Acta Pol Pharm"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00001-14","article-title":"Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method","volume":"52","author":"Marchaim D","year":"2014","unstructured":"Marchaim D, Pogue JM, Tzuman O, et al.. Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method. J Clin Microbiol. 2014, 52:1617-21. 10.1128\/JCM.00001-14","journal-title":"J Clin Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02037-12","article-title":"Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens","volume":"50","author":"Zarkotou O","year":"2012","unstructured":"Zarkotou O, Pournaras S, Altouvas G, et al.. Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens. J Clin Microbiol. 2012, 50:3747-50. 10.1128\/JCM.02037-12","journal-title":"J Clin Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3844\/ajidsp.2012.65.69","article-title":"Antibiotic sensitivity pattern of blood isolates of Acinetobacter species in a tertiary care hospital: a retrospective analysis","volume":"8(1)","author":"Shareek PS","year":"2012","unstructured":"Shareek PS, Sureshkumar D, Ramasubramanian V, et al.. Antibiotic sensitivity pattern of blood isolates of Acinetobacter species in a tertiary care hospital: a retrospective analysis. Am J Infect Dis. 2012, 8(1):65-9. 10.3844\/ajidsp.2012.65.69","journal-title":"Am J Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2020\/45997.14206","article-title":"Impact of efflux pump inhibitor carbonyl-cyanide M-chlorophenylhydrazone in multidrug resistant Acinetobacter species isolates from sterile body fluids","author":"Raza S","year":"2020","unstructured":"Raza S, Gautam H, Maheshwari B, et al.. Impact of efflux pump inhibitor carbonyl-cyanide M-chlorophenylhydrazone in multidrug resistant Acinetobacter species isolates from sterile body fluids. J Clin Diagnostic Res. 2020, 1-4. 10.7860\/JCDR\/2020\/45997.14206","journal-title":"J Clin Diagnostic Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.10376","article-title":"In-vitro activity of tigecycline and comparator agents against common pathogens: Indian experience","volume":"13","author":"Veeraraghavan B","year":"2019","unstructured":"Veeraraghavan B, Poojary A, Shankar C, et al.. In-vitro activity of tigecycline and comparator agents against common pathogens: Indian experience. J Infect Dev Ctries. 2019, 13:245-50. 10.3855\/jidc.10376","journal-title":"J Infect Dev Ctries"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10040382","article-title":"Antibiotic resistance and genotypes of nosocomial strains of Acinetobacter baumannii in Kazakhstan","volume":"10","author":"Lavrinenko A","year":"2021","unstructured":"Lavrinenko A, Sheck E, Kolesnichenko S, Azizov I, Turmukhambetova A. Antibiotic resistance and genotypes of nosocomial strains of Acinetobacter baumannii in Kazakhstan. Antibiotics (Basel). 2021, 10:10.3390\/antibiotics10040382","journal-title":"Antibiotics (Basel)"},{"key":"ref29","article-title":"Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?","volume":"37(4)","author":"Grandesso S","year":"2014","unstructured":"Grandesso S, Sapino B, Amici G, Mazzucato S, Solinas M, Gion M. Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?. New Microbiol. 2014, 37(4):503-8.","journal-title":"New Microbiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00119-10","article-title":"Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC","volume":"48","author":"Torrico M","year":"2010","unstructured":"Torrico M, Gonz\u00e1lez N, Gim\u00e9nez MJ, et al.. Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC. J Clin Microbiol. 2010, 48:2243-6. 10.1128\/JCM.00119-10","journal-title":"J Clin Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462912-reliability-of-the-e-test-and-vitek-2-compact-for-tigecycline-susceptibility-testing-in-clinical-acinetobacter-baumannii-isolates-compared-with-broth-microdilution","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T18:36:55Z","timestamp":1772995015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462912-reliability-of-the-e-test-and-vitek-2-compact-for-tigecycline-susceptibility-testing-in-clinical-acinetobacter-baumannii-isolates-compared-with-broth-microdilution"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.104860","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,8]]}}}